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Background: The Patient Reported Outcomes Information System (PROMIS) is an efficient metric able to detect changes in
global health.
Purpose: To assess the responsiveness, convergent validity, and clinically important difference (CID) of PROMIS compared with
disease-specific scales after knee arthroscopy.
Study Design: Cohort study (Diagnosis); Level of evidence, 2.
Methods: A prospective institutional review board–approved study collected PROMIS Physical Function (PF), PROMIS Pain Inter-
ference (PI), International Knee Documentation Committee (IKDC), and Knee injury and Osteoarthritis Outcome Score (KOOS)
results in patients undergoing knee arthroscopy. The change from preoperative to longest follow-up was used in analyses per-
formed to determine responsiveness, convergent validity, and minimal and moderate CID using the IKDC scale as the anchor.
Results: Of the 100 patients enrolled, 76 were included. Values of the effect size index (ESI) ranged from near 0 to 1.69 across
time points and were comparable across scales. Correlations of the change in KOOS and PROMIS with IKDC ranged from r val-
ues of 0.61 to 0.79. The minimal CID for KOOS varied from 12.5 to 17.5. PROMIS PF and PI minimal CID were 3.3 and 23.2.
KOOS moderate CID varied from 14.3 to 18.8. PROMIS PF and PI moderate CID were 5.0 and 25.8.
Conclusion: The PROMIS PF and PI showed similar responsiveness and CID compared with disease-specific scales in patients
after knee arthroscopy. PROMIS PI, PROMIS PF, and KOOS correlations with IKDC demonstrate that these scales are measuring
a similar construct. The ESIs of PROMIS PF and PI were similar to those of KOOS and IKDC, suggesting similar responsiveness at
6 months or longer (ESI .1.0). Minimum and moderate CID values calculated for PROMIS PF and PI using IKDC as an anchor
were sufficiently low to suggest clinical usefulness.
Clinical Relevance: PROMIS PF and PI can be accurately used to determine improvement or lack thereof with clinically important
changes after knee arthroscopy.
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Knee arthroscopy is the most commonly performed ambu-
latory surgical procedure by orthopaedic surgeons, reach-
ing nearly 1 million procedures annually in the US in
2006.21,25 Knee arthroscopy techniques have evolved over
the years and are used to treat a variety of knee conditions
including meniscal tear, chondral defects, ligamentous
injury, loose body, and synovial hyperplasia.25 Current edi-
torials call for orthopaedic providers to assess varied
orthopaedic surgery procedures using patient-reported
outcomes (PROs).5,29 Regulations such as the Patient Pro-
tection and Affordable Care Act in 2010 expanded federal
oversight of tracking and reporting quality measures
including PROs.7 Likewise, current Medicare policy has
linked up to 9% of hospital payment to performance.7
Given these current research, regulatory, and reimburse-
ment incentives, PROs are now an important component
for tracking the success of orthopaedic procedures, includ-
ing arthroscopic knee surgery.
Generic global health PRO scales have distinct advan-
tages over disease-specific scales but are not fully vali-
dated. A multitude of disease-specific PROs are available,
including the International Knee Documentation Commit-
tee (IKDC), Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC), Western Ontario Meniscal
Evaluation Tool, and Knee injury and Osteoarthritis Out-
come Score (KOOS).2,11,12,18,19,30,31 Disease-specific scales
are designed to measure pain and functional deficits for a par-
ticular joint (eg, IKDC for the knee) or type of problem (eg,
WOMAC for osteoarthritis). In contrast, global health PRO
scales such as the Patient Reported Outcomes Information
System (PROMIS) are not limited to a particular joint or
type of disease.8,20 A concern is that because the PROMIS
scales are not disease specific, the scales may not demon-
strate responsiveness or detect change well. Another concern
is that other, non–knee related problems that also influence
pain and function might mask benefits that patients experi-
ence after procedures like knee arthroscopy.
Documenting responsiveness and detectable change may
significantly affect the clinical application and address rea-
sonable concerns regarding global health scales. Respon-
siveness is defined as the ability of a scale to detect
change over time. Responsiveness is assessed across scales
using the effect size index (ESI), where the change in a par-
ticular PRO scale is divided by the SD of the change.17 The
ESI essentially normalizes the PRO change scores for com-
parison across scales.17 When PRO scales are applied in
patient care, it is also beneficial to know what level of
change is needed such that the patient will note a perceived
benefit.24 Minimal and moderate clinically important differ-
ences (CIDs) inform a clinician of what change score is asso-
ciated with a minimal and moderate level of perceived
improvement. The CID for minimal improvement on the
IKDC is 11.5 and for moderate improvement is 20.5.19 The
IKDC is commonly used and well validated.9,11,22,23 How-
ever, minimal and moderate CID for the KOOS is not well
established in patients after knee arthroscopy. The
PROMIS scales are new, with no studies of responsiveness
and minimal/moderate CID addressing knee arthroscopy
patients directly.10,13 Also, to date most studies of PROMIS
CID used distribution method approaches rather than pre-
ferred anchor method approaches.4,13
The appeal of generic health measures such as PROMIS
is great, as these scales capture overall health rather than
disease-specific effects, are quick to administer, and allow
comparison across disease conditions with limited patient
burden, lending themselves to the addition of other health
domains that affect health care, such as mental or social
health. The ability to measure generic health domains
informs clinicians of how procedures like knee arthroscopy
are influencing overall health rather than only focal
disease-specific effects.16 Further, because PROMIS scales
use computer adaptive test (CAT) algorithms, they take
less time than most disease-specific scales.14,15,27 For
example, previously published data have determined that
the CAT for the PROMIS Physical Function (PF) scale is
administered in 6 to 12 questions per patient and the
IKDC consists of 18 static questions with an average com-
pletion time of 85 seconds and 195 seconds, respectively.27
The purpose of this study was to determine whether the
PROMIS scales are responsive and able to detect meaning-
ful clinical change similarly to disease-specific scales
(IKDC and KOOS) across the continuum of care from 2
weeks to 12 months in patients who underwent knee
arthroscopy. The first hypothesis was that the selected
PROMIS scales would show similar responsiveness as
measured by the ESI compared with the KOOS and
IKDC scales from preoperative to longest follow-up. The
second hypothesis was that the change in scores (preoper-
ative to longest follow-up) for the PROMIS scales and
KOOS subscales would show similar convergence (correla-
tion) with the change in IKDC scales. The third hypothesis
was that the minimal and moderate CID for the PROMIS
and KOOS scales would show similar accuracy in deter-
mining the minimal and moderate CID on the IKDC scale.
METHODS
Patients were prospectively enrolled into an institutional
review board–approved study (the University of Rochester
approved the study protocol) to determine the responsive-
ness of PROMIS, KOOS, and IKDC scales for patients
undergoing knee arthroscopy for medial meniscal tear, lat-
eral meniscal tear, chondromalacia, loose body, and/or
synovial hyperplasia. Included patients were over 18 years
old and underwent primary knee arthroscopy with partial
medial meniscectomy, partial lateral meniscectomy, chon-
droplasty, loose body removal, and/or synovectomy.
Patients were excluded who had revision surgery or liga-
mentous injury or were non–English speaking. We
enrolled 100 patients, accounting for a possible dropout
of 30 patients, based on a Pearson correlation power anal-
ysis showing adequate power of 70 with a low-moderate
correlation r value of 0.33, a = .05, and b = .20. PROMIS
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(PF) and Pain Interference (PI) scales, IKDC, and KOOS
were collected at preoperative and postoperative visits
through use of iPads and were stored using the REDcap
system.28 The time to collect PROMIS data has been
reported in previous studies to be 2.4 minutes, and the
data are instantaneously viewed in the electronic record
for patient engagement and shared decision making on
treatment plans.14,15,27,28 All PROMIS CAT scores are pre-
sented as t scores with a score of 50 linked to the mean of
the 2010 US Census data. Every 10 points represent 1 SD.
Higher scores on the PROMIS PF indicate better function.
In contrast, lower scores on the PROMIS PI indicate less
pain.6
Statistical Analysis
The change from preoperative to the longest follow-up point
on average was evaluated across all participants using anal-
ysis of variance (ANOVA) and t tests to examine the sample
and follow-up period. The longest follow-up period varied
widely, from 2 weeks to 12 months (Table 1). This ensured
a wide range of change scores across the sample. To describe
the preoperative to longest follow-up characteristics of the
sample on the PRO scales, separate 2-way ANOVA models
were used for KOOS and PROMIS, and a paired t test was
used for the IKDC scale. The 2 factors were time (preopera-
tive, longest follow-up) and each outcome’s subscales or
domains. The 5 subscales of the KOOS were Symptoms,
Pain, Activities of Daily Living (ADL), Sports, and Quality
of Life. The PROMIS had 2 domains: PF and PI. A main
effect for KOOS was consistent with improvement across
subscales. However, this was also followed by pairwise
comparisons to verify that each subscale documented
improvement over the time interval. An interaction
effect was consistent with improvement across scales for
PROMIS because the scales show improvement differently
(improvement for PF is a higher t score and improvement
for PI is a lower t score). This was followed by pairwise com-
parisons for each domain.
The ESI was used for all changes in scores to determine
responsiveness.17 The ESI is a common index of change to
judge responsiveness of scales, where higher values indi-
cate better responsiveness.17 Values of 0.2 are considered
low effects, 0.5 medium effects, and above 0.8 large
effects.17 Scales that show higher ESIs are able to detect
change better than scales with lower ESI values. The
change evaluated was the preoperative to longest follow-
up (all participants) and each subgroup of time intervals
(2 weeks, 3 months, 6 months, and 12 months). Although
group membership was small for some time intervals
(n = 11-23 for subgroups), the subgroup analysis provides
preliminary data for exploring whether responsiveness
may vary for some time intervals.
Pearson correlation coefficients were used to determine
the convergent validity of the different scales to detect
IKDC change. Pearson correlation coefficients (r values)
were calculated for the change from preoperative to longest
follow-up for the KOOS and PROMIS with the IKDC total
scores. Because the KOOS and PROMIS PF and PI scales
measure similar constructs to the IKDC scale, convergence
or higher correlations were expected.
To evaluate what values might be used to judge minimal
and moderate CID, the IKDC scale was used as the anchor.
The IKDC scale is validated, and both minimal and moderate
CID have been established.18,19 Preoperative to postoperative
change in IKDC scores of 11.5 was used to indicate a minimal
CID and 20.5 was used to indicate a moderate CID.18 Only
improvement was evaluated in this study. After coding
(0,1) minimal and moderate CID, receiver operating charac-
teristic (ROC) curve analysis was used to determine the accu-
racy of each scale in documenting a minimal or moderate
CID. The area under the curve (AUC) is a global measure
of accuracy that can be used to compare scales.4,13,17 An
AUC above 0.7 is considered clinically useful and above 0.9
highly accurate.26 The ROC curve analysis was sensitive to
prevalence of minimal and moderate change as defined by
the IKDC scale. Therefore, the prevalence of CID (moderate)
was used to estimate the adequacy of the sample size. With
a minimum sample of 74 participants and an AUC of 0.7,
the estimated 95% CI for the AUC at 10% increments for
the prevalence of CID was calculated. A prevalence of 20%
or higher resulted in the 95% CI for the AUC excluding 0.5.
The threshold for change was chosen based on the clos-
est point (ie, shortest distance) to no errors on the ROC
curve (sensitivity = 1, specificity = 0) to determine what
change was ideal. Although different approaches can be
used, preliminary analysis showed that for most scales
there was a clear shortest distance.13,19 Where there was
no clear shortest distance, the threshold lying in the mid-
dle of thresholds that resulted in similar shortest distance
was used. The thresholds for each KOOS subscale and
PROMIS scale are reported along with their sensitivity
and specificity.
TABLE 1
Demographics and Follow-upa
Variable Finding
Age, y 48.9 6 11.1 (20-74)
Male sex, n (%) 40 (52.6)
Height, cm 171.5 6 9.6 (152.0-196.0)
Weight, kg 89.7 6 20.6 (49.4-143.8)
Body mass index, kg/m2 30.5 6 6.6 (19.3-48.0)
Injured knee (right), n (%) 39 (51.3)
Follow-up, n (%)
2 weeks 11 (14.5)
3 months 15 (19.7)
6 months 26 (34.2)
12 months 24 (31.6)
International Knee Documentation
Committee scale, n (%)
Minimal CID (.11.5) 51 (67.1)
Moderate CID (.20.5) 37 (48.7)
aValues are expressed as average 6 SD (range) unless other-
wise noted. CID, clinically important difference.
RESULTS
Participants
Participants varied on several demographic and clinical
variables (Table 1). After exclusion of participants who
lacked demographic data, preoperative data, and follow-
up data points, a total of 76 records were available for anal-
ysis. All 76 patients had completed preoperative data and
at least one set of complete postoperative data. Partici-
pants ranged in follow-up time from 2 weeks (13.6%) to
12 months (29.6%). Average 6 SD age was 48.9 6 11.1
years (range, 20-74 years). Body mass index also indicated
variability with an average 6 SD of 30.5 6 6.6 kg/m2
(range, 19.3-48 kg/m2). The proportion of participants
experiencing a minimal CID improvement on the IKDC
scale was 67.1%. The proportion experiencing a moderate
CID improvement on the IKDC scale was slightly lower
at 48.7%. With the exception of the KOOS ADL scale,
which has 9 missing values, all other scales were missing
fewer than 4 values (see values listed next to each scale
in tables).
Change From Preoperative to Longest Follow-up
Despite the varied follow-up times, the average values
preoperatively were significantly improved on all PROs
at longest follow-up (Table 2). The ANOVA model main
effect for KOOS (P \ .01) and interaction effect for
PROMIS (P \ .01) scales were both significant. The
KOOS scales all statistically improved (P \ .05), with
improvement ranging from 17.5 6 16.7 on the ADL sub-
scale to 24.0 6 30.0 on the Sports subscale (Table 2).
The PROMIS scales also statistically improved for each
scale, where the PROMIS PF improved 6.3 6 7.3 and PI
improved 26.2 6 6.7 (Table 2). The paired t test compar-
ing preoperative IKDC with longest follow-up on the
IKDC scale showed significant improvement of 20.2 6
18.4 points (P \ .01).
Responsiveness as Indicated by the Effect Size Index
Values of the ESI ranged from near 0 to 1.69 across the var-
ious time points (Table 3). At the 2-week time point, ESI val-
ues above 0.5 included IKDC (0.54), KOOS Symptoms (0.51)
and KOOS Pain (0.68). All other scales were between 0.2 and
0.5 except PROMIS PF (0.04) and KOOS Sports (0.04). At 3
months, all scales showed an ESI above 0.5. Three of the ESI
values for the KOOS subscales were above 0.8: Pain (1.05),
ADL (0.84), and Sports (0.84). At 6 and 12 months, all scales
were higher than 1.13. For the interval from preoperative to
longest follow-up, all scales were higher than 0.8.
KOOS and PROMIS Correlation With IKDC
The KOOS and PROMIS scales all showed significant corre-
lations with the IKDC scale. The correlations ranged from
0.61 to 0.79. The PROMIS domain scales PF and PI, which
were 0.76 and 20.67, were within the range of KOOS sub-
scales (r values ranged from 0.61 to 0.79) (Table 4).
Minimal Clinically Important Difference
The AUCs for all PROs were significant for predicting
patients who experienced a minimal CID (Table 5). The
KOOS subscales showed AUC between 0.78 and 0.92 (Fig-
ure 1). The minimal CID for the KOOS subscales varied
from 12.5 to 17.5 on a 100-point scale. The sensitivity and
specificity varied from 63.2% to 91.3%. The PROMIS PF
and PI scales showed AUC values of 0.88 and 0.85, respec-
tively (Figure 2). The minimal CIDs for the PROMIS PF
and PI scales were 3.3 and 23.2, respectively. The sensitiv-
ity and specificity varied from 75.0% to 86.0% (Table 5).
Moderate Clinically Important Difference
The AUCs for all PROs were significant for predicting
patients who experienced a moderate CID (Table 6). The
KOOS subscales showed AUCs between 0.79 and 0.86
TABLE 2
Patient-Reported Outcomes at Preoperative Point and Longest Follow-up, and Changes Between These Valuesa
Preoperative Longest Follow-up Change
n Mean 6 SD Range n Mean 6 SD Range Mean 6 SD Range P Value
KOOS
Symptoms 76 54.5 6 20.3 0-89.3 75 72.8 6 19.8 10.7-100 18.4 6 19.4 –35.7 to 57.1 \.01
Pain 76 54.0 6 16.6 0-91.7 74 75.5 6 17.9 25.0-100 21.5 6 18.1 –22.0 to 69.4 \.01
ADL 74 63.1 6 17.9 1.5-100 68 80.2 6 17.8 30.9-100 17.5 6 16.7 –30.9 to 55.9 \.01
Sports 74 31.8 6 21.7 0-80 74 56.1 6 31.6 0-100 24.0 6 30.0 –50.0 to 100 \.01
QOL 76 31.2 6 15.8 0-75 75 53.0 6 21.9 0-100 22.0 6 21.3 –37.5 to 68.8 \.01
PROMIS
PF 76 40.1 6 6.2 27.2-63.5 75 46.4 6 8.7 28.8-70.3 6.3 6 7.3 –7.8 to 31.3 \.01
PI 76 59.7 6 6.1 38.7-74.1 73 53.6 6 8.0 38.7-74.1 –6.2 6 6.7 –25.5 to 11.2 \.01
IKDC
Total 76 41.1 6 15.8 6.9-86.2 76 60.8 6 21.2 16.1-100 20.2 6 18.4 –15.0 to 66.7 \.01
aADL, Activities of Daily Living; IKDC, International Knee Documentation Committee; KOOS, Knee injury and Osteoarthritis Outcome
Score; PF, Physical Function; PI, Pain Interference; PROMIS, Patient Reported Outcomes Information System; QOL, Quality of Life.
(Figures 1 and 2). The moderate CID for the KOOS sub-
scales, determined by taking the shortest distance to a
perfect score on the ROC, varied from 14.3 to 18.8 on
a 100-point scale. The sensitivity and specificity varied
from 61.8% to 88.8%. The PROMIS PF and PI scales
showed AUC values of 0.89 for both scales (Figures 3 and
4). The moderate CIDs for the PROMIS PF and PI scales
were 5.0 and 25.8, respectively. The sensitivity and speci-
ficity varied from 71.8% to 88.9%.
DISCUSSION
The new findings of this analysis are that PROMIS PF and
PI scales show similar responsiveness to selected disease-
specific scales in knee arthroscopy patients. Except for the
2-week time point, all scales demonstrated ESI above 0.5,
suggesting at least medium ability or above to detect
change. The correlations between the PROMIS and KOOS
scales with the IKDC scales demonstrated convergence.
This finding supports the construct of the PROMIS PF
and PI scales as the comparable disease-specific scales (ie,
KOOS and IKDC). The minimal and moderate CID across
the PROMIS and KOOS scales suggest that both scales
are likely useful to detect change. Aside from the 2-week
time point, the data support the ability of PROMIS PF
and PI to detect change in patients after knee arthroscopy.
Rather than use a standardized follow-up point, this
analysis used a wide range of follow-up points (2 weeks to
a minimum of 12 months). This sampling strategy ensures
a wide range of change scores across the continuum of recov-
ery (see Table 2). This sampling strategy resulted in 67.1%
and 48.7% of participants meeting minimal and moderate
CID criteria on the IKDC scale, respectively. The advantage
of this approach is that a wide range of change scores are
represented in the sample. Therefore, the ability of the
scales to detect change across time points is evaluated.
The disadvantage is that average improvements hold little
meaning relative to overall outcome. However, all PRO
scales showed significant aggregate improvement (see Table
2). The current sample is representative of a wide range of
clinical responses across the continuum of care that led to
a higher proportion of patients meeting criteria for
‘‘improved’’ and ‘‘not improved’’ in this analysis.
The correlation of the PROMIS scale change scores
demonstrates convergent validity with the IKDC scale.
The hypothesis that the PROMIS PF and PI scales share
similar constructs with the IKDC scales was supported.
The convergences of PROMIS PF and PI were 0.76 and
20.67, respectively. The negative correlation between
PROMIS PI and IKDC was consistent with the fact that
higher scores on the PROMIS PI scale indicate worse
pain interference while lower scores on IKDC indicate
worse function. The strength of the PROMIS PF and PI
correlations were similar to the KOOS subscales, which
varied from 0.61 to 0.79. This suggests that despite includ-
ing only global health items, the PROMIS PF and PI scales
showed similar convergence as a disease-specific scale.
These correlation data suggest that the PROMIS PF and
PI capture similar constructs associated with patient func-
tioning and pain as the IKDC scale.
TABLE 3
Effect Size Index Values for the Entire Group and at Each Time Pointa
2 Weeks 3 Months 6 Months 12 Months All
KOOS
Symptoms 0.51 (n = 11) 0.49 (n = 14) 1.13 (n = 26) 1.56 (n = 23) 0.95 (n = 74)
Pain 0.68 (n = 10) 1.05 (n = 15) 1.46 (n = 25) 1.36 (n = 23) 1.19 (n = 73)
ADL 0.47 (n = 10) 0.84 (n = 14) 1.26 (n = 23) 1.58 (n = 20) 1.05 (n = 67)
Sports 0.04 (n = 11) 0.84 (n = 14) 1.15 (n = 25) 1.15 (n = 22) 0.80 (n = 72)
QOL 0.75 (n = 11) 0.48 (n = 15) 1.30 (n = 25) 1.44 (n = 24) 1.03 (n = 75)
PROMIS
PF 0.04 (n = 11) 0.54 (n = 15) 1.14 (n = 25) 1.33 (n = 24) 0.86 (n = 75)
PI 0.44 (n = 11) 0.54 (n = 14) 1.25 (n = 25) 1.27 (n = 23) 0.93 (n = 73)
IKDC
Total 0.54 (n = 11) 0.64 (n = 15) 1.33 (n = 26) 1.69 (n = 24) 1.10 (n = 76)
aADL, Activities of Daily Living; IKDC, International Knee Documentation Committee; KOOS, Knee injury and Osteoarthritis Outcome
Score; PF, Physical Function; PI, Pain Interference; PROMIS, Patient Reported Outcomes Information System; QOL, Quality of Life.
TABLE 4
Correlations of the Change From Preoperative to Longest
Follow-up With the Change of the IKDC Scalea
n r Value P Value
KOOS
Symptoms 74 0.61 \.01
Pain 73 0.74 \.01
ADL 67 0.70 \.01
Sports 72 0.79 \.01
QOL 75 0.72 \.01
PROMIS
PF 75 0.76 \.01
PI 73 –0.67 \.01
aADL, Activities of Daily Living; IKDC, International Knee
Documentation Committee; KOOS, Knee injury and Osteoarthri-
tis Outcome Score; PF, Physical Function; PI, Pain Interference;
PROMIS, Patient Reported Outcomes Information System; QOL,
Quality of Life.
This study improves on previous studies by reporting
CID changes using the IKDC as an anchor or reference
for change (Tables 5 and 6). Previous studies have used
the distribution method, which determines the minimal
CID as one-half SD of the change for the PROMIS PF
and PI scales.4,13 Their values for minimal CID were as
high as 5.8.4,13 This contrasts with an anchor-based
method applied to patients with low back pain. PROMIS
PI values of 3.5 to 5.5 were considered meaningful for these
participants corresponding to a minimal CID.1 The data
from the present study suggest that a minimal CID is 3.2
to 3.3 and a moderate CID is 5.0 to 5.8 for PROMIS PF
and PI, which are similar to other anchor-based estimates1
and lower than distribution-based estimates.4,13 It remains
unclear whether there are distinct differences in minimal
and moderate CID across diagnoses. The AUC values for
the PROMIS PF and PI scales were above 0.85 for both
minimal (Table 5) and moderate (Table 6) CID. This was
similar to the KOOS subscales, whose AUC values ranged
from 0.78 to 0.92 for minimal CID and 0.79 to 0.87 for mod-
erate CID. This suggests that both the PROMIS PF and PI
scales had similar accuracy to a disease-specific scale in
identifying change on the IKDC. The sensitivity and spec-
ificity of the PROMIS PF and PI scales were also similar
for the identified CID values compared with the KOOS
subscales. Overall, the PROMIS PI and PF scales’ minimal
and moderate CID values appear to perform similarly to
those of a comparative disease-specific scale (ie, KOOS).
The clinical implication of this study is that PROMIS
PF and PI are likely equally as effective at tracking patient
recovery after knee arthroscopy as disease-specific scales.
An advantage to using PROMIS PF and PI clinically is
that improvements due to arthroscopic knee surgery are
associated with global health rather than specific to the
knee. The only caution seen in these data is the low ESI
at 2 weeks. PROMIS may also be used to satisfy federal
regulation and performance metrics used in evolving reim-
bursement models. Advantages to the PROMIS scales are
TABLE 5
Receiver Operating Characteristic Curve Analysis Based on 11.5 Change
in IKDC Scale at Longest Follow-up (2 weeks to 12 months)a
Scale Threshold AUC 95% CI P Value Sensitivity Specificity
PROMIS
PF 3.3 0.88 (0.04) 0.81-0.96 \.001 86.0 76.0
PI –3.2 0.85 (0.04) 0.77-0.94 \.001 83.7 75.0
KOOS
Symptoms 16.0 0.78 (0.06) 0.66-0.90 \.001 72.2 73.9
Pain 12.5 0.84 (0.05) 0.73-0.94 \.001 81.1 63.2
ADL 12.6 0.86 (0.05) 0.76-0.97 \.001 86.1 78.3
Sports 17.5 0.88 (0.04) 0.80-0.97 \.001 80.6 82.6
QOL 15.6 0.92 (0.04) 0.84-1.00 \.001 83.3 91.3
aADL, Activities of Daily Living; AUC, area under the curve; IKDC, International Knee Documentation Committee; KOOS, Knee injury
and Osteoarthritis Outcome Score; PF, Physical Function; PI, Pain Interference; PROMIS, Patient Reported Outcomes Information System;
QOL, Quality of Life. Values in parentheses are standard error.
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Figure 1. Receiver operating characteristic curve of minimal
clinically important differences (CIDs) for Knee injury and
Osteoarthritis Outcome Score (KOOS) scales. ADL, Activities
of Daily Living.
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Figure 2. Receiver operating characteristic curve of moder-
ate clinically important differences (CID) for Knee injury and
Osteoarthritis Outcome Score (KOOS) scales. ADL, Activities
of Daily Living.
that they are agnostic to diagnosis and therefore more eas-
ily applied than disease-specific scales across a wide spec-
trum of patients. In addition, use of the CAT approach
decreases data collection time and the results are dis-
played in the electronic medical record, making it a useful
tool in high-flow practice models.28
Limitations
The limitations of this study are also important to consider.
The advantage of a sample with varied follow-up was a wide
variance in the change scores. An alternative sampling
approach would be prospective data of a larger sample at
standardized time points. This directly affects the ESI
data shown at different time points. The 2-week time point
is undersampled but demonstrates how prospective data at
multiple time points would be useful to understand the
responsiveness of scales across recovery. Applying the cur-
rent minimal and moderate CID values to a separate
sample would also validate the generalizability of the CID
values.3,4 Other approaches to determining the CID value
include the interquartile range and using other Likert scale
approaches.1 The results of this study are dependent on the
validity of the IKDC scale as an anchor.9,11,22,23
CONCLUSION
The global health PROMIS PF and PI scales showed simi-
lar ability to detect change to that of disease-specific meas-
ures for patients recovering from knee arthroscopy.
Specifically, the responsiveness of the PROMIS PF and
PI scales was similar to that of the KOOS and IKDC.
The PROMIS PF and PI showed similar convergence
with IKDC to the KOOS, suggesting that these scales mea-
sure similar constructs associated with physical ability and
pain. Finally, minimal and moderate CID values were cal-
culated for PROMIS PF and PI and KOOS; such values
will assist with clinical decisions regarding whether
TABLE 6
Receiver Operating Characteristic Curve Analysis Based on 20.5 Change
in IKDC Scale at Longest Follow-up (2 weeks to 12 months)a
Scale Threshold AUC 95% CI P Value Sensitivity Specificity
PROMIS
PF 5.0 0.89 (0.04) 0.81-0.96 \.001 88.9 71.8
PI –5.8 0.89 (0.04) 0.82-0.96 \.001 85.7 78.9
KOOS
Symptoms 14.3 0.79 (0.06) 0.67-0.90 \.001 84.0 61.8
Pain 18.1 0.86 (0.05) 0.76-0.95 \.001 88.0 74.5
ADL 15.4 0.82 (0.05) 0.72-0.93 \.001 80.0 67.6
Sports 17.5 0.87 (0.04) 0.79-0.96 \.001 88.0 67.6
QOL 18.8 0.86 (0.04) 0.76-0.95 \.001 88.0 76.5
aADL, Activities of Daily Living; AUC, area under the curve; IKDC, International Knee Documentation Committee; KOOS, Knee injury
and Osteoarthritis Outcome Score; PF, Physical Function; PI, Pain Interference; PROMIS, Patient Reported Outcomes Information System;
QOL, Quality of Life. Values in parentheses are standard error.
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Figure 3. Receiver operating characteristic curve of minimal
clinically important differences (CIDs) for the Patient
Reported Outcomes Information System (PROMIS).
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Figure 4. Receiver operating characteristic curve of moder-
ate clinically important differences (CIDs) for the Patient
Reported Outcomes Information System (PROMIS).
patients are significantly improved as they recover from
knee arthroscopy and can guide patients in clinical deci-
sion making with recovery.
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